• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Charles & Colvard Ltd filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Unregistered Sales of Equity Securities, Leadership Update, Financial Statements and Exhibits

    6/27/25 4:11:01 PM ET
    $CTHR
    Consumer Specialties
    Consumer Discretionary
    Get the next $CTHR alert in real time by email
    false 0001015155 0001015155 2025-06-24 2025-06-24 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

     

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    FORM 8-K

    CURRENT REPORT

    PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

     

    Date of Report (Date of earliest event reported): June 24, 2025

     

    Charles & Colvard, Ltd.

    (Exact name of registrant as specified in its charter)

     

    North Carolina 000-23329 56-1928817

    (State or other jurisdiction of

    incorporation)

    (Commission File

    Number)

    (I.R.S. Employer

    Identification No.)

     

    170 Southport Drive  
    Morrisville, North Carolina 27560
    (Address of principal executive offices) (Zip Code)

     

    (919) 468-0399

    (Registrant’s telephone number, including area code)

     

    N/A

    (Former name or former address, if changed since last report) 

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

     

    ¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
       
    ¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
       
    ¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
       
    ¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

     

    Securities registered pursuant to Section 12(b) of the Act: None.

     

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

     

    Emerging growth company     ¨

     

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.     ¨

     

     

     

     

     

     

    Item 1.01 Entry into a Material Definitive Agreement.

     

    Convertible Secured Note Purchase Agreement

     

    On June 24, 2025, Charles & Colvard, Ltd. (the “Company”) entered into a Convertible Secured Note Purchase Agreement (the “Note Purchase Agreement”) with Ethara Capital LLC (the “Holder”), a Delaware limited liability company. In connection with the Note Purchase Agreement, the Company agreed to issue a convertible secured note (the “Note”) to the Holder for an aggregate total purchase price of $2.0 million, to be issued in two tranches: (i) an initial closing in the amount of $500,000 (the “Original Principal Amount”) on or before July 8, 2025 (the “First Closing”), and (ii) a subsequent and final closing of $1.5 million (the “Additional Principal Amount”) on such date as the Company and the Holder thereafter agree, but no later than July 23, 2025 (the “Second Closing,” and together with the First Closing, the “Closings”).

     

    The principal amount on which interest will accrue is equal to the Original Principal Amount as such amount may be (i) increased by payment of PIK Interest (as defined below), (ii) increased by the Additional Principal Amount, and (iii) reduced pursuant to any conversion or redemption effected in accordance with the terms of the Note (such balance from time to time being the “Accreted Principal Amount”). Interest will accrue on the Accreted Principal Amount at an annual rate equal to 5%, payable monthly at the Holder’s discretion in either (i) cash or (ii) an increase in the Accreted Principal Amount by the amount of interest payable (the “PIK Interest”). Subject to obtaining Company shareholder approval first, the Holder may, in its sole discretion, convert all or any portion of the Accreted Principal Amount (plus accrued and unpaid interest) into shares of the Company’s common stock (the “Conversion Shares”) at any time after the issuance of the Note pursuant to its terms. The Accreted Principal Amount, together with any accrued and unpaid interest, shall be due and payable three months following the date the Note is issued (the “Maturity Date”). The Holder may irrevocably elect to extend the Maturity Date for three periods of up to one year each, provided that the Maturity Date cannot be extended later than thirty-nine months following the date the Note is issued. The Second Closing is conditioned on the absence of both an Event of Default and Fundamental Change (each as defined in the Note). The Note is secured by the Company’s Collateral, as defined in the Security Agreement discussed below, but subordinated to the Company’s debt to Wolfspeed, Inc.

     

    The Company agreed to enter into a registration rights agreement relating to the registration for resale of the Conversion Shares within 30 days after the date of the Second Closing. The Note also contains Company restrictive affirmative and negative covenants regarding the operation of its business.

     

    The issuance of the Note was made in reliance upon the exemption provided by Section (4)(a)(2) of the Securities Act of 1933, as amended (the “Securities Act”), for the offer and sale of securities not involving a public offering, and Regulation D promulgated under the Securities Act.

     

    Security Agreement

     

    On the date of the First Closing, the Company and the Holder will enter into a security agreement (the “Security Agreement”), granting in favor of the Holder a security interest in all tangible and intangible personal property of the Company. On the date of the Second Closing, the Security Agreement will reflect the Additional Principal Amount.

     

    Director Appointment Rights

     

    In connection with the Note Purchase Agreement, the Holder received the right to appoint two directors to the Company’s board of directors (the “Board”) prior to the date of the First Closing. Upon the Second Closing, the Holder has the right to appoint two observers to the Board.

     

    Item 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.

     

    The information included in Item 1.01 of this Current Report on Form 8-K is incorporated by reference into this Item 2.03 of this Current Report on Form 8-K.

     

    Item 3.02 Unregistered Sales of Equity Securities.

     

    The information included in Item 1.01 of this Current Report on Form 8-K is incorporated by reference into this Item 3.02 of this Current Report on Form 8-K.

     

    2 

     

     

    Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

     

    As a condition to the Company’s entry into the Note Purchase Agreement, each of Don O’Connell, the Company’s Chief Executive Officer, and Clint J. Pete, the Company’s Chief Financial Officer, agreed to waive all severance benefits to which they would otherwise be entitled under their respective employment agreements. Prior to the date of the Closings, Mr. Don O’Connell and Mr. Pete will execute waivers regarding their rights to severance benefits.

     

    The foregoing descriptions of the Note Purchase Agreement, and the forms of Note and Security Agreement, do not purport to be complete and are qualified in their entirety by the full text of the Note and the Subsidiary Guaranty, copies of which are filed as exhibits to this Current Report on Form 8-K and incorporated herein by reference.

     

    Item 9.01. Financial Statements and Exhibits.

     

    (d) Exhibits.

     

    Exhibit

    Number

      Description
         
    10.1   Convertible Secured Note Purchase Agreement, dated June 24, 2025, by and between the Company and the Holder.
         
    10.2   Form of Secured Convertible Note.
         
    10.3   Form of Security Agreement.
         
    104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

     

    3 

     

     

    SIGNATURE

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     

      Charles & Colvard, Ltd.
         
    June 27, 2025 By /s/ Clint J. Pete
        Clint J. Pete
        Chief Financial Officer

     

    4 

     

    Get the next $CTHR alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CTHR

    DatePrice TargetRatingAnalyst
    9/3/2021$3.50 → $3.75Buy
    Roth Capital
    More analyst ratings

    $CTHR
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Charles & Colvard Partners with VideoShops to Bring Its Lab-Grown Jewelry and Customers to the Social Commerce Network with 50,000+ Influential Sellers

    RESEARCH TRIANGLE PARK, N.C., Nov. 17, 2025 /PRNewswire/ -- Charles & Colvard, Ltd. (OTC:CTHR) (the "Company"), a globally recognized fine jewelry company that specializes in moissanite and lab-grown diamonds, today announced a strategic partnership with VideoShops, a next-generation social commerce network built to change how commerce flows through social with over 50,000 sellers transforming how people shop, share, and engage with today's consumers. "We believe this partnership underscores Charles & Colvard's ongoing commitment to digital innovation, transparency, and shoppa

    11/17/25 8:30:00 AM ET
    $CTHR
    Consumer Specialties
    Consumer Discretionary

    CHARLES & COLVARD PARTNERS WITH ETHARA CAPITAL TO EXPAND LAB-GROWN DIAMOND OFFERINGS

    RESEARCH TRIANGLE PARK, N.C., Oct. 9, 2025 /PRNewswire/ -- Charles & Colvard, Ltd. (OTC:CTHR) (the "Company"), a globally recognized fine jewelry company that specializes in moissanite and lab-grown diamonds, today announced plans to expand its lab-grown diamond ("LGD") offerings to consumers as well as wholesale markets with the supply chain support from its strategic investor, Ethara Capital ("Ethara"), whose affiliates pioneered Chemical Vapor Deposition LGD manufacturing, and own and operate over 3,000 diamond-growing machines today. In June, Ethara Capital announced a Con

    10/9/25 8:30:00 AM ET
    $CTHR
    Consumer Specialties
    Consumer Discretionary

    Charles & Colvard, Ltd. Announces Delisting from Nasdaq

    RESEARCH TRIANGLE PARK, N.C., April 22, 2025 /PRNewswire/ -- Charles & Colvard, Ltd. ("Charles & Colvard" or the "Company"), announced that the Company received a staff determination letter from the Nasdaq Stock Market, LLC ("Nasdaq"), informing the Company that Nasdaq determined to suspend trading and delist the Company's common stock (the "Common Stock") from Nasdaq because the Company is out of compliance with Listing Rule 5250(c)(1) for failure to timely file its Forms 10-Q for the quarters ended September 30 and December 31, 2024, unless the Company appeals this determination. The Company does not intend to request a hearing to appeal this determination. This decision was based on a car

    4/22/25 4:45:00 PM ET
    $CTHR
    Consumer Specialties
    Consumer Discretionary

    $CTHR
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Roth Capital reiterated coverage on Charles & Colvard with a new price target

    Roth Capital reiterated coverage of Charles & Colvard with a rating of Buy and set a new price target of $3.75 from $3.50 previously

    9/3/21 8:46:46 AM ET
    $CTHR
    Consumer Specialties
    Consumer Discretionary

    $CTHR
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    O'Connell Don bought $5,550 worth of shares (15,000 units at $0.37) (SEC Form 4)

    4 - CHARLES & COLVARD LTD (0001015155) (Issuer)

    3/7/24 4:15:57 PM ET
    $CTHR
    Consumer Specialties
    Consumer Discretionary

    Sykes Ollin B bought $7,028 worth of shares (19,000 units at $0.37) (SEC Form 4)

    4 - CHARLES & COLVARD LTD (0001015155) (Issuer)

    3/5/24 6:21:11 PM ET
    $CTHR
    Consumer Specialties
    Consumer Discretionary

    O'Connell Don bought $4,806 worth of shares (13,350 units at $0.36), increasing direct ownership by 3% to 464,464 units (SEC Form 4)

    4 - CHARLES & COLVARD LTD (0001015155) (Issuer)

    3/5/24 9:15:15 AM ET
    $CTHR
    Consumer Specialties
    Consumer Discretionary

    $CTHR
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    New insider Ethara Capital Llc claimed ownership of 1,353,180 shares (SEC Form 3)

    3 - CHARLES & COLVARD LTD (0001015155) (Issuer)

    10/9/25 3:30:05 PM ET
    $CTHR
    Consumer Specialties
    Consumer Discretionary

    O'Connell Don bought $5,550 worth of shares (15,000 units at $0.37) (SEC Form 4)

    4 - CHARLES & COLVARD LTD (0001015155) (Issuer)

    3/7/24 4:15:57 PM ET
    $CTHR
    Consumer Specialties
    Consumer Discretionary

    Sykes Ollin B bought $7,028 worth of shares (19,000 units at $0.37) (SEC Form 4)

    4 - CHARLES & COLVARD LTD (0001015155) (Issuer)

    3/5/24 6:21:11 PM ET
    $CTHR
    Consumer Specialties
    Consumer Discretionary

    $CTHR
    SEC Filings

    View All

    Charles & Colvard Ltd filed SEC Form 8-K: Leadership Update

    8-K - CHARLES & COLVARD LTD (0001015155) (Filer)

    1/7/26 4:45:55 PM ET
    $CTHR
    Consumer Specialties
    Consumer Discretionary

    Charles & Colvard Ltd filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

    8-K - CHARLES & COLVARD LTD (0001015155) (Filer)

    10/16/25 4:30:36 PM ET
    $CTHR
    Consumer Specialties
    Consumer Discretionary

    SEC Form NT 10-K filed by Charles & Colvard Ltd

    NT 10-K - CHARLES & COLVARD LTD (0001015155) (Filer)

    9/30/25 5:20:02 PM ET
    $CTHR
    Consumer Specialties
    Consumer Discretionary

    $CTHR
    Leadership Updates

    Live Leadership Updates

    View All

    Milestone Scientific Announces CEO Transition, with Chairman Neal Goldman Serving as Interim CEO

    ROSELAND, N.J., Nov. 14, 2024 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced that its Chief Executive Officer Arjan Haverhals will retire from his role as an officer of the company on December 31, 2024. Upon his retirement, Mr. Haverhals will continue to serve as a director on the Board and will provide consulting services to ensure continuity and support through the leadership transition. Mr. Haverhals' retirement, following a distinguished career of over 30 years in the medical device and pharmaceutical industries, reflects his desire to spend more ti

    11/14/24 4:00:00 PM ET
    $CTHR
    $MLSS
    Consumer Specialties
    Consumer Discretionary
    Industrial Specialties
    Health Care

    Charles & Colvard Joins Russell Microcap® Index

    RESEARCH TRIANGLE PARK, N.C., June 28, 2021 /PRNewswire/ -- Charles & Colvard, Ltd. (NASDAQ:CTHR) (the "Company"), a globally recognized fine jewelry company specializing in lab created moissanite and lab grown diamonds, announced today the Company's addition to the Russell Microcap® Index, effective after the US market opens on June 28, 2021, as a part of the Russell indexes annual reconstitution. Membership in the Russell Microcap® Index, which remains in place for one year, means automatic inclusion in the appropriate growth and value style indexes. FTSE Russell determines

    6/28/21 9:16:00 AM ET
    $CTHR
    Consumer Specialties
    Consumer Discretionary

    $CTHR
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13D/A filed by Charles & Colvard Ltd (Amendment)

    SC 13D/A - CHARLES & COLVARD LTD (0001015155) (Subject)

    2/26/24 7:00:57 PM ET
    $CTHR
    Consumer Specialties
    Consumer Discretionary

    SEC Form SC 13G/A filed by Charles & Colvard Ltd (Amendment)

    SC 13G/A - CHARLES & COLVARD LTD (0001015155) (Subject)

    2/14/24 9:00:30 AM ET
    $CTHR
    Consumer Specialties
    Consumer Discretionary

    SEC Form SC 13D/A filed by Charles & Colvard Ltd (Amendment)

    SC 13D/A - CHARLES & COLVARD LTD (0001015155) (Subject)

    11/20/23 4:15:12 PM ET
    $CTHR
    Consumer Specialties
    Consumer Discretionary

    $CTHR
    Financials

    Live finance-specific insights

    View All

    CHARLES & COLVARD REPORTS THIRD QUARTER FISCAL YEAR 2024 FINANCIAL RESULTS

    Conference Call with Accompanying Slide Presentation Scheduled Today at 4:30 PM ET RESEARCH TRIANGLE PARK, N.C., May 2, 2024 /PRNewswire/ -- Charles & Colvard, Ltd. (NASDAQ:CTHR) (the "Company"), a globally recognized fine jewelry company that specializes in moissanite and lab grown diamonds, reported financial results for the third quarter ended March 31, 2024 ("Third Quarter Fiscal 2024").  Management Commentary  "We remain committed to growth despite a challenging third quarter. We believe our strategic initiatives, continued investments in innovative technology, and dedica

    5/2/24 4:07:00 PM ET
    $CTHR
    Consumer Specialties
    Consumer Discretionary

    CHARLES & COLVARD TO HOST THIRD QUARTER FISCAL YEAR 2024 INVESTOR CONFERENCE CALL ON MAY 2, 2024 AT 4:30 PM ET

    RESEARCH TRIANGLE PARK, N.C., April 23, 2024 /PRNewswire/ -- Charles & Colvard, Ltd. (NASDAQ:CTHR) (the "Company"), a globally recognized fine jewelry company that specializes in moissanite and lab grown diamonds, will host an investor conference call and webcast presentation to discuss its financial results for the third quarter ended March 31, 2024 ("Third Quarter Fiscal Year 2024") at 4:30 p.m. ET on Thursday, May 2, 2024. The Company will release its financial results after market close on the same day. Third Quarter Fiscal Year 2024 Conference Call DetailsDate and Time: T

    4/23/24 4:08:00 PM ET
    $CTHR
    Consumer Specialties
    Consumer Discretionary

    CHARLES & COLVARD REPORTS SECOND QUARTER FISCAL YEAR 2024 FINANCIAL RESULTS

    Conference Call with Accompanying Slide Presentation Scheduled Today at 4:30 PM ET RESEARCH TRIANGLE PARK, N.C., Feb. 13, 2024 /PRNewswire/ -- Charles & Colvard, Ltd. (NASDAQ:CTHR) (the "Company"), a globally recognized fine jewelry company that specializes in moissanite and lab grown diamonds, reported financial results for the second quarter ended December 31, 2023 ("Second Quarter Fiscal 2024").  Management Commentary  "We acknowledge the recent industry shift has presented us with numerous challenges and has significantly impacted our earnings. However, we do not believe t

    2/13/24 4:07:00 PM ET
    $CTHR
    Consumer Specialties
    Consumer Discretionary